RAMM Pharma Corp. (CSE:RAMM)

RAMM Pharma Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	0.12	0.8	0.81	5.12	9.77	17.16
Cash & Short-Term Investments	0.12	0.8	0.81	5.12	9.77	17.16
Cash Growth	-83.96%	-1.25%	-84.09%	-47.65%	-43.03%	-38.74%
Accounts Receivable	0.08	0.45	0.78	0.62	0.92	1.17
Other Receivables	0.36	0.43	0.86	1.26	1.83	2.78
Receivables	0.45	0.88	1.64	1.88	2.74	3.95
Inventory	0.73	0.93	2.54	3.14	4.02	3.05
Prepaid Expenses	0.01	0.03	0.26	0.22	0.08	0.06
Other Current Assets	0.01	0	0.1	0.24	0.03	0.06
Total Current Assets	1.32	2.64	5.36	10.59	16.65	24.28
Property, Plant & Equipment	5.81	6.63	11.2	19.05	19.71	19.34
Goodwill	-	-	-	-	-	12.85
Other Intangible Assets	0	0	0.19	0.49	0.8	1.47
Other Long-Term Assets	-	-	-	2.17	2.08	1.86
Total Assets	7.13	9.27	16.75	32.3	39.24	59.8

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Accounts Payable	0.16	0.38	0.64	1.21	1.11	1.93
Accrued Expenses	0.17	0.28	0.36	0.33	0.56	0.48
Current Portion of Leases	0.04	0.07	0.1	0.23	0.23	0.03
Current Income Taxes Payable	-	-	0.01	0.01	0.01	0
Other Current Liabilities	2.41	2.83	1.92	0.87	1.3	0.87
Total Current Liabilities	2.78	3.56	3.03	2.66	3.2	3.32
Long-Term Leases	-	0.01	0.08	0.18	0.45	0
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.09
Total Liabilities	2.78	3.57	3.11	2.84	3.66	3.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Common Stock	60.99	60.99	60.99	60.99	62.52	63.06
Additional Paid-In Capital	7.17	7.17	6.87	3.05	1.36	1.36
Retained Earnings	-75.86	-74.82	-65.91	-49.45	-43.09	-22.44
Comprehensive Income & Other	12.04	12.36	11.69	14.88	14.79	14.42
Shareholders' Equity	4.35	5.7	13.63	29.46	35.59	56.39
Total Liabilities & Equity	7.13	9.27	16.75	32.3	39.24	59.8

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Total Debt	0.04	0.08	0.19	0.41	0.68	0.03
Net Cash (Debt)	0.08	0.72	0.63	4.71	9.09	17.12
Net Cash Growth	-89.26%	15.62%	-86.72%	-48.16%	-46.92%	-38.64%
Net Cash Per Share	0.00	0.01	0.01	0.04	0.07	0.16
Filing Date Shares Outstanding	119.39	119.39	119.39	119.39	122.4	123.45
Total Common Shares Outstanding	119.39	119.39	119.39	119.39	122.4	123.45
Working Capital	-1.46	-0.92	2.33	7.93	13.45	20.97
Book Value Per Share	0.04	0.05	0.11	0.25	0.29	0.46
Tangible Book Value	4.34	5.69	13.45	28.97	34.78	42.07
Tangible Book Value Per Share	0.04	0.05	0.11	0.24	0.28	0.34
Land	1.39	2.48	3.7	4.58	4.42	4.18
Machinery	5.25	5.5	5.66	6.06	5.82	4.76
Construction In Progress	3.13	3.3	6.32	12.05	11.96	12.66

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error